Skip to main content

Table 2 Demographic and clinical characteristics of HIV-infected patients

From: Pyroptosis associated with immune reconstruction failure in HIV-1- infected patients receiving antiretroviral therapy: a cross-sectional study

 

INR

n = 57

IR

n = 56

NC

n = 22

Gender

   

 Male

78.9% (45)

55.4% (31)

45.5% (10)

 Female

21.1% (12)

44.6% (25)

54.5% (12)

Age (years)

   

 21–40

12.3% (7)

23.2% (13)

18.2% (4)

 41–60

52.6% (30)

66.1% (37)

54.5% (12)

 61–80

35.1% (20)

10.7% (6)

27.3% (6)

BMI

19.39 ± 4.45

20.54 ± 2.26

20.06 ± 6.24

HIV transmission category

   

 Heterosexual

96.5% (55)

98.2% (55)

100% (22)

 Homosexual

3.5% (2)

0.0%

0.0%

 Injection drug user

0.0%

1.8% (1)

0.0%

Regimen

   

 TDF + 3TC + EFV

61.4% (35)

44.6% (25)

68.2% (15)

 AZT/3TC + EFV

19.3% (11)

23.2% (13)

18.2% (4)

 Other

19.3% (11)

32.2% (18)

10.7% (3)

Baseline CD4+ T Counts (cells/μL)

92.91 ± 94.53

115.22 ± 79.29

561 ± 199.91

Baseline CD8+ T Counts (cells/μL)

785.41 ± 462.31

728.01 ± 437.47

1165.41 ± 488.1

Baseline CD4/CD8 ratio

0.13 ± 0.15

0.18 ± 0.15

0.53 ± 0.18

Baseline WBC (× 109 / L)

5.04 ± 1.61

5.03 ± 1.86

7.65 ± 3.62

Last CD4+ T Counts (cells/μL)

145.11 ± 36.43

404.64 ± 122.41

727.91 ± 188.07